Our findings of increased Rab12 phosphorylation and pS106-Rab12 labeling of GVBs and pathology across synucleinopathies and tauopathies suggest that LRRK2 plays a role in other neurodegenerative diseases in addition to Parkinsonism. Here, RAB12 is linked to neurodegenerative disease.